Pages
- Academy
- Beyond Tesla: Major Automakers Investing Heavily in Electric Vehicle Production
- CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals
- CNS Pharmaceuticals Announces Brain Cancer Patient from Berubicin Phase 1 Trial Remains Cancer Free
- CNS Pharmaceuticals Announces Filing of FDA Orphan Drug Designation for Brain Cancer Drug Berubicin
- CNS Pharmaceuticals Announces Independent University Research Confirms Active Compound in WP1122 Completely Prevents Coronavirus Replication In Vitro
- CNS Pharmaceuticals Filed Request with FDA for Pre-IND Meeting for Berubicin
- CNS Pharmaceuticals Partnered with Anthem Biosciences Pvt. Ltd. in Preparation for Upcoming Proposed Phase 2 Clinical Trial
- CNS Pharmaceuticals Received Positive FDA Pre-IND Guidance for Berubicin
- CNS Pharmaceuticals Signs Agreement with WPD Pharmaceuticals to Develop Drug Candidates for a Range of Viruses including Coronavirus for International Markets
- CNS Pharmaceuticals to Collaborate with WPD Pharmaceuticals on Active Compound That Reduces Coronavirus Replication in Vitro by 100%.
- CNS Pharmaceuticals, Inc Signs Agreement with WPD Pharmaceuticals to Develop Drug Candidates for Viruses including Coronavirus
- Contact Us
- DropCar and AYRO Stockholders Approve Merger
- Guide
- Home
- How to profit from the EV revolution (without buying a single automaker stocks)
- Philanthropy in Finance
- Pre-IPO Directory
- Privacy Policy
- Risk Disclosure
- Sitemap
- Terms and Conditions
- WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral Indications
Posts
Archives
- January 2019 (2)
- December 2018 (1)
- June 2018 (3)